- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 324-338 of
901 results
2006 Exhibit: EX2006 Scheduling Order, Novo Nordisk Inc v Rio Biopharms, Inc, No...
Document
IPR2024-00009, No. 2006 Exhibit - EX2006 Scheduling Order, Novo Nordisk Inc v Rio Biopharms, Inc, No 122 cv 00294 CFC, Dkt 22 D Del (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
2011 Exhibit: EX2011 US Patent No 8,114,833
Document
IPR2024-00009, No. 2011 Exhibit - EX2011 US Patent No 8,114,833 (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
1018 Exhibit: Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL M...
Document
IPR2024-00009, No. 1018 Exhibit - Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL MED 25 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
... of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2026 Exhibit - EX2026 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 0303
|
|
Cite Document
... of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2024 Exhibit - EX2024 Excerpt of Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 030
|
|
Cite Document
1099 Exhibit: Proposed Stipulation
Document
IPR2024-00009, No. 1099 Exhibit - Proposed Stipulation (P.T.A.B. Mar. 29, 2024)
|
|
Cite Document
2021 Exhibit: EX2021 Compilation of Rule 30b1 Deposition Notices, In re Ozempic ...
Document
IPR2024-00009, No. 2021 Exhibit - EX2021 Compilation of Rule 30b1 Deposition Notices, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
1059 Exhibit: Murphy, Review of the Safety, 46 ANNALS OF PHARMACOTHERAPY...
Document
IPR2024-00009, No. 1059 Exhibit - Murphy, Review of the Safety, 46 ANNALS OF PHARMACOTHERAPY 812 2012 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1038 Exhibit: Seino, Dose Dependent, 81 DIABETES RSCH CLINICAL PRACTICE 1...
Document
IPR2024-00009, No. 1038 Exhibit - Seino, Dose Dependent, 81 DIABETES RSCH CLINICAL PRACTICE 161 2008 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1014 Exhibit: Clinical Trial No NCT00851773
Document
IPR2024-00009, No. 1014 Exhibit - Clinical Trial No NCT00851773 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1013 Exhibit: Clinical Trial No NCT00696657
Document
IPR2024-00009, No. 1013 Exhibit - Clinical Trial No NCT00696657 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1092 Exhibit: CV of Dr Russell M Zusman
Document
IPR2024-00009, No. 1092 Exhibit - CV of Dr Russell M Zusman (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1066 Exhibit: Knudsen, Liraglutide, INT’L J CLINICAL PRACTICE 4 2010
Document
IPR2024-00009, No. 1066 Exhibit - Knudsen, Liraglutide, INT’L J CLINICAL PRACTICE 4 2010 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1089 Exhibit: Claim Construction Order, No 22 MD 3038 D Del July 25, 2023, ECF 1...
Document
IPR2024-00009, No. 1089 Exhibit - Claim Construction Order, No 22 MD 3038 D Del July 25, 2023, ECF 148 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1030 Exhibit: Kim, Effects of Once Weekly Dosing, 30 DIABETES CARE 1487 2007
Document
IPR2024-00009, No. 1030 Exhibit - Kim, Effects of Once Weekly Dosing, 30 DIABETES CARE 1487 2007 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
